Cellectis (CLLS) Misses Q3 EPS by 3c

Cellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.23), $0.03 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $18.05 million versus the consensus estimate of $9.77 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
• Veeva Systems (VEEV) Tops Q1 EPS by 10c, Offers Guidance